Patent intelligence · US
US 11278494
Manufacturing of bupivacaine multivesicular liposomes
Manufacturing of bupivacaine multivesicular liposomes
Patent details — US 11278494
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 22, 2022
- Expiration
- Mar 17, 2042
- Applicant
- Pacira Pharmaceuticals, Inc.
- Claims
- 60
- CPC classes
- A61K, A61K31/445, A61K47/12, A61K47/14
Quick answer
US 11278494 (Manufacturing of bupivacaine multivesicular liposomes) is held by Pacira Pharmaceuticals, Inc.. Status: granted. Granted Mar 22, 2022. Expires Mar 17, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Pacira Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 60
- CPC classes
- A61K, A61K31/445, A61K47/12, A61K47/14, A61K47/183, A61K47/26
More from Pacira Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12370142
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12364764
Sustained release thermosetting gels comprising sodium channel blockers and the methods of making same
granted -
US 12318483
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12296047
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12285435
Multivesicular liposome formulations of dexamethasone
granted -
US 12285419
Bupivacaine multivesicular liposome formulations and uses thereof
granted -
US 12280149
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12251472
Manufacturing of bupivacaine multivesicular liposomes
granted
Frequently asked questions
What is US patent 11278494?
US 11278494 (Manufacturing of bupivacaine multivesicular liposomes) is held by Pacira Pharmaceuticals, Inc.. Status: granted. Granted Mar 22, 2022. Expires Mar 17, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11278494?
Pacira Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 57 pharmaceutical patents for this assignee.
When does US 11278494 expire?
Our index shows an expiration date of Mar 17, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.